Compare · ACLS vs DHR
ACLS vs DHR
Side-by-side comparison of Axcelis Technologies Inc. (ACLS) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACLS operates in Technology, while DHR operates in Industrials - the two are in different parts of the market.
- DHR is the larger of the two at $145.10B, about 33.9x ACLS ($4.28B).
- Over the past year, ACLS is up 94.9% and DHR is up 5.3% - ACLS leads by 89.7 points.
- DHR has been more active in the news (7 items in the past 4 weeks vs 1 for ACLS).
- DHR has more recent analyst coverage (25 ratings vs 17 for ACLS).
- Company
- Axcelis Technologies Inc.
- Danaher Corporation
- Price
- $139.44-3.78%
- $205.02+2.15%
- Market cap
- $4.28B
- $145.10B
- 1M return
- -27.12%
- +13.22%
- 1Y return
- +94.94%
- +5.26%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- News (4w)
- 1
- 7
- Recent ratings
- 17
- 25
Axcelis Technologies Inc.
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest ACLS
- Amendment: SEC Form SCHEDULE 13G/A filed by Axcelis Technologies Inc.
- SVP Interim CFO Ryzhik David covered exercise/tax liability with 76 shares, decreasing direct ownership by 0.76% to 9,955 units (SEC Form 4) to satisfy tax liability
- EVP, Research, Dev. & Eng. Blumenstock Gerald M covered exercise/tax liability with 506 shares, decreasing direct ownership by 2% to 19,987 units (SEC Form 4) (for tax liability)
- Director Sayiner Necip sold $249,703 worth of shares (1,586 units at $157.44), decreasing direct ownership by 18% to 7,112 units (SEC Form 4)
- EVP Global Operations Mahoney Robert John sold $179,302 worth of shares (1,155 units at $155.24), decreasing direct ownership by 7% to 14,410 units (SEC Form 4)
- VP Corporate Controller Sutton Todd sold $319,980 worth of shares (2,000 units at $159.99), decreasing direct ownership by 24% to 6,360 units (SEC Form 4)
- SEC Form SD filed by Axcelis Technologies Inc.
- Director St Dennis Thomas sold $139,833 worth of shares (900 units at $155.37), decreasing direct ownership by 5% to 17,695 units (SEC Form 4)
- EVP, General Counsel and Sec'y Evans Eileen sold $143,998 worth of shares (926 units at $155.51), decreasing direct ownership by 3% to 31,295 units (SEC Form 4)
- EVP, Research, Dev. & Eng. Blumenstock Gerald M sold $177,285 worth of shares (1,161 units at $152.70), decreasing direct ownership by 5% to 20,493 units (SEC Form 4)
Latest DHR
- VP, Chief Accounting Officer Bouda Christopher covered exercise/tax liability with 60 shares, decreasing direct ownership by 0.65% to 9,107 units (SEC Form 4)
- Director Filler Linda exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 9% to 26,829 units (SEC Form 4)
- Director Zerhouni Elias A. exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 45,303 units (SEC Form 4)
- Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems
- Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
- Danaher Schedules Second Quarter 2026 Earnings Conference Call
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
- SEC Form 11-K filed by Danaher Corporation
- Piper Sandler initiated coverage on Danaher with a new price target
- Danaher Completes Acquisition of Masimo Corporation